Literature DB >> 11158005

Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds.

S J Hasstedt1, Q F Ren, K Teng, S C Elbein.   

Abstract

The Pro(12)Ala (P12A) variant of exon B of the peroxisome proliferator-activated receptor gamma(2) (PPAR gamma) been variably associated with obesity, insulin sensitivity, diabetes, and dyslipidemia, but its role in insulin resistance-associated traits remains uncertain. We tested the hypothesis that this variant is associated with the insulin resistance syndrome by genotyping 619 members of 52 familial type 2 diabetes kindreds. A subset of 124 family members underwent iv glucose tolerance tests and minimal model determination of insulin sensitivity. We estimated the frequency of the A12 allele as 0.12, within the range observed in random Caucasian samples. We were unable to demonstrate any effect on direct measures of insulin sensitivity, and no trait was linked to markers near PPAR gamma on chromosome 3q. However, body mass index, serum total cholesterol levels, triglyceride levels, systolic and diastolic blood pressures, and glucose concentration showed at least a trend to association (P < 0.1) when tested separately for a family-based association. When these 6 traits were included in a multivariate analysis, body mass index, systolic and diastolic blood pressures, triglyceride levels, and glucose concentration remained significantly associated with the P12A variant (P < 0.05), whereas the effect of P12A on liability for diabetes was not significant. The predicted means for each trait and each genotype suggested that the P12A variant acted most like a recessive mutation, with the major effect among homozygous individuals who comprise only 1--2% of the population. We confirm an association of the P12A variant in traits commonly ascribed to the insulin resistance syndrome, but not with direct measures of insulin sensitivity. The tendency for this variant to act in a recessive manner with effects on multiple traits may explain the inconsistent associations noted in previous studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158005     DOI: 10.1210/jcem.86.2.7205

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Dynamic correlation networks in human peroxisome proliferator-activated receptor-γ nuclear receptor protein.

Authors:  Jeremy Fidelak; Silvia Ferrer; Michael Oberlin; Dino Moras; Annick Dejaegere; Roland H Stote
Journal:  Eur Biophys J       Date:  2010-05-23       Impact factor: 1.733

Review 3.  PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.

Authors:  Simona Cataldi; Valerio Costa; Alfredo Ciccodicola; Marianna Aprile
Journal:  Curr Diab Rep       Date:  2021-04-18       Impact factor: 4.810

4.  Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes.

Authors:  K B Adamo; R J Sigal; K Williams; G Kenny; D Prud'homme; F Tesson
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

5.  Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease.

Authors:  Jean Dallongeville; Carlos Iribarren; Jean Ferrières; Liisa Lyon; Alun Evans; Alan S Go; Dominique Arveiler; Stephen P Fortmann; Pierre Ducimetière; Mark A Hlatky; Philippe Amouyel; Audrey Southwick; Thomas Quertermous; Aline Meirhaeghe
Journal:  PPAR Res       Date:  2009-12-01       Impact factor: 4.964

6.  Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure.

Authors:  Yau-Sheng Tsai; Lonquan Xu; Oliver Smithies; Nobuyo Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-02       Impact factor: 11.205

7.  Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms.

Authors:  R Baratta; R Di Paola; D Spampinato; G Fini; A Marucci; A Coco; R Vigneri; L Frittitta; V Trischitta
Journal:  J Mol Med (Berl)       Date:  2003-10-22       Impact factor: 4.599

Review 8.  The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Authors:  S E Kahn
Journal:  Diabetologia       Date:  2003-01-11       Impact factor: 10.122

9.  Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.

Authors:  M Ben Hadj Mohamed; N Mtiraoui; I Ezzidi; M Chaieb; T Mahjoub; W Y Almawi
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

10.  Association of PPAR-γ2 and β3-AR Polymorphisms With Postmenopausal Hypertension.

Authors:  Bogna Grygiel-Górniak; Elżbieta Kaczmarek; Maria Mosor; Juliusz Przysławski; Jerzy Nowak
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-31       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.